Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01189 (
beta-endorphin
)
21,003
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
D-Amino acid substitutions in the anti-inflammatory/antipyretic Ac-
alpha-MSH
(11-13)-NH2 tripeptide of Ac-
alpha-MSH
(1-13)-NH2 were made and the altered peptides were injected in mice treated with picryl chloride.
Ear swelling
, measured 3 and 6 h after application of the irritant, was reduced by IP injections of Ac-
alpha-MSH
(11-13)-NH2, in confirmation of previous observations. Ac-[D-Lys11]
alpha-MSH
(11-13)-NH2 effected similar anti-inflammatory activity but Ac-[D-Pro12]
alpha-MSH
(11-13)-NH2 was inactive. Ac-[D-Val13]
alpha-MSH
(11-13)-NH2 and Ac-[D-Lys11,D-Val13]
alpha-MSH
(11-13)-NH2 generally had greater anti-inflammatory activity than the parent tripeptide molecule; the dose-response relations exhibited the bell-shaped characteristics seen previously with MSH peptides. The results indicate that the L-Pro12 is essential for the anti-inflammatory activity of Ac-
alpha-MSH
(11-13)-NH2 whereas the L-Lys11 is not. D-Val13 substitution increased anti-inflammatory activity approximately four-fold over Ac-
alpha-MSH
(11-13)-NH2. These results provide new structure-activity relationships of the anti-inflammatory Ac-
alpha-MSH
(11-13)-NH2 molecule. The data support the developing idea that
alpha-MSH
and its COOH-terminal fragments modulate host responses, perhaps by antagonizing the actions of cytokines.
...
PMID:Anti-inflammatory activity of alpha-MSH(11-13) analogs: influences of alteration in stereochemistry. 178 40